Clover Biopharmaceuticals became the sixth Chinese developer of a potential COVID-19 vaccine to move into human trials on Friday, launching a study in Australia that will test its vaccine with boosters.
FILE PHOTO: Small bottles labeled with a"Vaccine COVID-19" sticker and a medical syringe are seen in this illustration taken taken April 10, 2020. REUTERS/Dado Ruvic
There are currently no approved vaccines or treatments for the illness caused by the new coronavirus, but about a dozen vaccines are being trailed globally.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
China's Clover begins human trials of COVID-19 shot with GSK, Dynavax boostersA potential coronavirus vaccine being developed by China's Clover Biopharmaceuticals using GlaxoSmithKline's vaccine booster is now in early-stage testing in humans, the companies said on Friday.
Weiterlesen »
China's Clover begins human trials of COVID-19 shot with GSK, Dynavax boostersA potential coronavirus vaccine being developed by China's Clover Biopharmaceuticals using GlaxoSmithKline's vaccine booster is now in early-stage testing in humans, the companies said on Friday.
Weiterlesen »
What will a COVID-19 vaccine look like? Don’t expect a cure-all, scientists sayData on close cousins of the COVID-19 virus, including seasonal coronaviruses that cause the common cold, suggests the COVID-19 vaccine probably won't offer lifelong protection.
Weiterlesen »
Moderna CEO sees 'high probability' of success with Covid-19 vaccineModerna is the front-runner in the race for a Covid-19 vaccine. Its CEO sees an 80% to 90% chance of success.
Weiterlesen »
Rare 'super' antibodies could be key in COVID-19 vaccine race"These neutralizing antibodies effectively keep the virus from entering human cells and could essentially knock out the infection," Dr. Neeta Ogden explained.
Weiterlesen »
Exclusive: EU in advanced talks with Johnson & Johnson on COVID-19 vaccine deal - sourcesThe European Commission is in advanced talks with pharmaceutical giant Johnson & Johnson to reserve or buy up-front doses of its COVID-19 vaccine under development, two officials familiar with the talks told Reuters.
Weiterlesen »